New Vernon Capital Holdings II »

Protagonist Therapeutics shares owned by New Vernon Capital Holdings II

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by New Vernon Capital Holdings II from 13F filings

Historical chart of New Vernon Capital Holdings II investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by New Vernon Capital Holdings II consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by New Vernon Capital Holdings II

Quarter filed Position value Share count Share price at filing
2025-09-30 $478k 7.2k 66.43
2025-06-30 $398k 7.2k 55.27
2025-03-31 $7.2M 348k 20.68
2024-12-31 $118k 3.1k 38.60

More positions owned by New Vernon Capital Holdings II

Icici Bank Adr (IBN)
Hdfc Bank Sponsored Ads (HDB)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Ishares Msci Sth Kor Etf (EWY)
Wisdomtree Tr India Erngs Fd (EPI)
Ishares Msci Singpor Etf (EWS)
Ishares Tr Msci India Etf (INDA)
Ishares Tr Msci Taiwan Etf (EWT)
Ishares Tr China Lg-cap Etf (FXI)
J P Morgan Exchange Traded F Betabuldrs Japan (BBJP)
Wisdomtree Tr Japn Hedge Eqt (DXJ)
Ishares Msci Cda Etf (EWC)
Infosys Sponsored Adr (INFY)
Ishares Msci Brazil Etf (EWZ)

View all positions for New Vernon Capital Holdings II

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
Rtw Investments
Vanguard Group
State Street Corporation
BVF
Johnson & Johnson
Wellington Management Company
UBS Group
Deep Track Capital
Woodline Partners
Geode Capital Management
Driehaus Capital Management
Henderson Group
Marshall Wace

View all funds holding Protagonist Therapeutics